NeoCore Technology Co., Ltd. (TPEX:4131)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.80
-1.10 (-2.90%)
Jun 18, 2026, 12:18 PM CST
Market Cap1.46B +9.4%
Revenue (ttm)235.54M +104.2%
Net Income-20.42M
EPS-0.52
Shares Out 39.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,030
Open37.30
Previous Close37.90
Day's Range36.80 - 37.30
52-Week Range30.10 - 42.45
Beta-0.28
AnalystsStrong Buy
Price Target192.55 (+423.23%)
Earnings DateAug 10, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 44
Stock Exchange Taipei Exchange
Ticker Symbol 4131
Full Company Profile

Financial Performance

In 2025, NeoCore Technology's revenue was 244.66 million, an increase of 297.52% compared to the previous year's 61.55 million. Losses were -30.87 million, -35.87% less than in 2024.

Financial Statements